Eleven Biotherapeutics Inc. (Nasdaq: EBIO) narrowed losses for the second quarter as revenue rose. Shares of the biopharmaceutical climbed 68 cents to close at $4.71.
Eleven Biotherapeutics narrows losses
August 12, 2016 at 20:11 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.